West Oak Capital, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
West Oak Capital, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2021$23,000
-47.7%
2000.0%0.01%
-47.1%
Q2 2021$44,000
+69.2%
2000.0%0.02%
+54.5%
Q1 2021$26,000
-25.7%
2000.0%0.01%
-31.2%
Q4 2020$35,000
+59.1%
2000.0%0.02%
+33.3%
Q3 2020$22,000
+83.3%
2000.0%0.01%
+71.4%
Q2 2020$12,000
-7.7%
2000.0%0.01%
-22.2%
Q1 2020$13,0002000.01%
Other shareholders
NOVOCURE LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders